The DOI matches its Crossref record; 240 of the 242 references it cites were found in a registry or an index.
Phages and their potential to modulate the microbiome and immunity
Open accessAbstract
Bacteriophages (hence termed phages) are viruses that target bacteria and have long been considered as potential future treatments against antibiotic-resistant bacterial infection. However, the molecular nature of phage interactions with bacteria and the human host has remained elusive for decades, limiting their therapeutic application. While many phages and their functional repertoires remain unknown, the advent of next-generation sequencing has increasingly enabled researchers to decode new lytic and lysogenic mechanisms by which they attack and destroy bacteria. Furthermore, the last decade has witnessed a renewed interest in the utilization of phages as therapeutic vectors and as a means of targeting pathogenic or commensal bacteria or inducing immunomodulation. Importantly, the narrow host range, immense antibacterial repertoire, and ease of manipulating phages may potentially allow for their use as targeted modulators of pathogenic, commensal and pathobiont members of the microbiome, thereby impacting mammalian physiology and immunity along mucosal surfaces in health and in microbiome-associated diseases. In this review, we aim to highlight recent advances in phage biology and how a mechanistic understanding of phage-bacteria-host interactions may facilitate the development of novel phage-based therapeutics. We provide an overview of the challenges of the therapeutic use of phages and how these could be addressed for future use of phages as specific modulators of the human microbiome in a variety of infectious and noncommunicable human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Phages can eliminate cancer-associated bacteria, remodel the tumor microenvironment, enhance antitumor immunity, and deliver targeted therapeutic payloads.”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, phage DNA and structural proteins engage pattern recognition receptors within innate immune pathways, thereby enhancing antitumor immune responses [21,23–26]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indirectly, phages reshape tumor-associated bacterial communities, depleting protumorigenic taxa and altering microbial metabolites that regulate inflammation, genotoxic stress, and therapeutic response [20–23]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indirectly, phages reshape tumor-associated bacterial communities, depleting protumorigenic taxa and altering microbial metabolites that regulate inflammation, genotoxic stress, and therapeutic response [20–23]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indirectly, phages reshape tumor-associated bacterial communities, depleting protumorigenic taxa and altering microbial metabolites that regulate inflammation, genotoxic stress, and therapeutic response [20–23]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [21]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Studies have begun uncovering direct and indirect immunomodulatory properties of phages beyond their antimicrobial effects [21,25,74]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–240 of 240
Short, F. L., Akusobi, C., Broadhurst, R. W., & Salmond, G. P. C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18696-x · Cited by 51
Sartorius, R., D’Apice, L., Trovato, M., Cuccaro, F., Costa, V., Leo, M. G. D., Marzullo, V. M., Biondo, C., D’Auria, S., Matteis, M. A. D., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404525 · Cited by 48
Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome
Gregory, A., Sullivan, M. B., Segal, L. N., & Keller, B. C. (2018) · Respiratory Research · doi:10.1186/s12931-018-0878-9 · Cited by 47
Bacteriophages engineered to display foreign peptides may become short‐circulating phages
Hodyra‐Stefaniak, K., Lahutta, K., Majewska, J., Kaźmierczak, Z. M., Lecion, D., Harhala, M. A., Kęska, W., Owczarek, B., Jończyk‐Matysiak, E., Kłopot, A., et al. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13414 · Cited by 47
Prophage genomics reveals patterns in phage genome organization and replicationPreprint
Kang, H. S., McNair, K. A., Cuevas, D., Bailey, B., Segall, A. M., & Edwards, R. A. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/114819 · Cited by 46
Liu, K.-Y., Yang, W., Dong, X., Cong, L.-M., Li, N., Li, Y., Wen, Z., Yin, Z., Lan, Z.-J., Li, W.-P., et al. (2016) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2015.1233 · Cited by 45
d’Humières, C., Touchon, M., Dion, S., Cury, J., Ghozlane, A., Garcia‐Garcerà, M., Bouchier, C., Ma, L., Denamur, É., & Rocha, E. P. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-47656-w · Cited by 45
Global phylogeography and ancient evolution of the widespread human gut virus crAssphagePreprint
Edwards, R. A., Vega, A. A., Norman, H., Ohaeri, M. C., Levi, K., Dinsdale, E. A., Cinek, O., Aziz, R. K., McNair, K. A., Barr, J. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/527796 · Cited by 43
Pulmonary Immune Responses to Propionibacterium acnes in C57BL/6 and BALB/c Mice
McCaskill, J. G., Chason, K. D., Hua, X., Neuringer, I. P., Ghio, A. J., Funkhouser, W. K., & Tilley, S. L. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0285oc · Cited by 40
Transmissible Toxicogenicity of Streptococci.
Frobisher, M., & Brown, J. H. (1927) · Bulletin of the Johns Hopkins Hospital · Cited by 40
Preparation of Metagenomic Libraries from Naturally Occurring Marine Viruses
Solonenko, S. A., & Sullivan, M. B. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-407863-5.00008-3 · Cited by 39
Beutin, L., Stroeher, U. H., & Manning, P. A. (1993) · Gene · doi:10.1016/0378-1119(93)90519-9 · Cited by 37
Bacteriophage–host interactions leading to genome internalization
Bertin, A., de Frutos, M., & Letellìer, L. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.010 · Cited by 35
Studies on bacteriophages ofPropionibacterium acnes
Jong, E. C., Ko, H. L., & Pulverer, G. (1975) · Medical Microbiology and Immunology · doi:10.1007/bf02122714 · Cited by 35
Yang, H., Xu, J., Li, W., Wang, S., Li, J., Yu, J., Li, Y., & Wei, H. (2018) · The EMBO Journal · doi:10.15252/embj.201798045 · Cited by 33
Yang, Y., Liu, Z., He, X., Yang, J., Wu, J., Yang, H., Li, M., Qian, Q., Lai, R., Xu, W., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006968 · Cited by 30
Kinetics of Targeted Phage Rescue in a Mouse Model of SystemicEscherichia coliK1
Schneider, G., Szentes, N., Horváth, M., Dorn, Á., Cox, A., Nagy, G., Doffkay, Z., Maróti, G., Rákhely, G., & Kovács, T. (2018) · BioMed Research International · doi:10.1155/2018/7569645 · Cited by 28
Latino, L., Midoux, C., Vergnaud, G., & Pourcel, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215456 · Cited by 28
McShan, W. M., & Ferretti, J. J. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.20.6509-6511.1997 · Cited by 25
Molecular mechanism of acquisition of the cholera toxin genes.
Das, B., Bischerour, J., & Barre, F. (2011) · PubMed Central · Cited by 24
Dixon, B. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00951-x · Cited by 23
Inducible Siphoviruses in superficial and deep tissue isolates of Propionibacterium acnes
Lood, R., Mörgelin, M., Holmberg, A. H., Rasmussen, M., & Collin, M. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-139 · Cited by 21
Figueroa‐Bossi, N., Ammendola, S., & Bossi, L. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.01.015 · Cited by 20
渡邊, 良. (2007) · Cited by 19
Direct sequencing of human gut virome fractions obtained by flow cytometry
Džunková, M., D’Auria, G., & Moyá, A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00955 · Cited by 18
Araya, D. V., Quiroz, T. S., Tobar, H. E., Lizana-Vera, R. J., Quezada, C. P., Santiviago, C. A., Riedel, C. A., Kalergis, A. M., & Bueno, S. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.073 · Cited by 18
Davidson, A. R. (2017) · Nature · doi:10.1038/nature21118 · Cited by 17
Sugar and Fatty Acids Ack-celerate Prophage Induction
Chatterjee, A., & Duerkop, B. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.012 · Cited by 16
Properties of Corynebacterium acnes Bacteriophage and Description of an Interference Phenomenon
Zierdt, C. H. (1974) · Journal of Virology · doi:10.1128/jvi.14.5.1268-1273.1974 · Cited by 16
Erratum: The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin
Liu, J., Yan, R., Zhong, Q., Ngo, S., Bangayan, N. J., Nguyen, L., Lui, T., Liu, M., Erfe, M. C. B., Craft, N. A., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2015.144 · Cited by 15
Beaudoin, J., & Pratt, D. (1974) · Journal of Virology · doi:10.1128/jvi.13.2.466-469.1974 · Cited by 15
Hynes, A. P., & Moineau, S. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.028 · Cited by 14
Crowd Controlled—Host Quorum Sensing Drives Phage Decision
Harms, A., & Diard, M. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.016 · Cited by 14
Blower, T. R., Short, F. L., Fineran, P. C., & Salmond, G. P. C. (2012) · Bacteriophage · doi:10.4161/bact.23830 · Cited by 13
Won, G., Eo, S. K., Park, S., Hur, J., & Lee, J. H. (2018) · Journal of Veterinary Science · doi:10.4142/jvs.2018.19.4.536 · Cited by 12
The human oral phageome is highly diverse and rich in jumbo phagesPreprint
Carr, V. R., Shkoporov, A. N., Gómez-Cabrero, D., Mullany, P. P., Hill, C., & Moyes, D. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.06.186817 · Cited by 10
Phage therapy: where East meets West
Debattista, J. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14789072.2.6.815 · Cited by 8
[Bacteriophages of Propionibacterium acnes (author's transl)].
Pulverer, G., Sorgo, W., & Hl, K. (1973) · PubMed · Cited by 8
Jakobsen, R. R., Haahr, T., Humaidan, P., Jensen, J. S., Kot, W., Castro-Mejia, J., Deng, L., Leser, T. D., & Nielsen, D. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/755710 · Cited by 6
Johnson, C. N., & Duerkop, B. A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0616-1 · Cited by 2
Research works printed but not linked: 1
- d'Hérelle, F. Sur un microbe invisible antagoniste des bacilles dysentériques. C. R. Acad. Sci. 165, 373–375 (1917).
Cited by
Sorted by citations
Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K., & Elinav, E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.006 · Cited by 578
Self-citationThe gut virome: A new microbiome component in health and disease
Cao, Z., Sugimura, N., Burgermeister, E., Ebert, M. P. A., Zuo, T., & Lan, P. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104113 · Cited by 303
Antibiotic failure: Beyond antimicrobial resistance
de la Fuente‐Núñez, C., Cesaro, A., & Hancock, R. E. W. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101012 · Cited by 274
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Jain, T., Sharma, P., Are, A. C., Vickers, S. M., & Dudeja, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622064 · Cited by 187
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Li, Z., Xiong, W., Zhu, L. W., Wang, J., Zeng, Z., Kołat, D., Li, X., Zhou, D., Xu, X., & Zhao, L.-Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01541-w · Cited by 197
Metadata
- Authors
- Federici, S., Nobs, S. P., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- German Cancer Research Center (DE)
- Corresponding author
- Elinav, Eran
- Venue
- Cellular & Molecular Immunology
- Published
- 2020-09-08
- Volume
- 18
- Issue
- 4
- Pages
- 889-904
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- PMC
- PMC8115240
- OpenAlex
- W3084223430
- Cited by
- 222
- References
- 242
- Citations by year
- 2026: 49 · 2025: 55 · 2024: 42 · 2023: 38 · 2022: 26 · 2021: 12
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- bacteriophages, phage therapy, human microbiome, phage-bacteria interactions, antibiotic resistance, immunomodulation, mucosal immunity, commensal bacteria, pathobionts, phage vectors
- MeSH terms
- Phage Therapy, Animals, Bacteria, Bacterial Infections, Bacteriophages, Humans, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
